{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "dd2f5f58-842b-4461-ab8e-71ed7595e23c", "code": "N0000000161", "comments": "Cellular or Molecular Interactions [MoA]|Receptor Interactions [MoA]|G-Protein-linked Receptor Interactions [MoA]|Adrenergic Receptor Interactions [MoA]|Adrenergic Antagonists [MoA]|Adrenergic beta-Antagonists [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000000161", "code_system": "NDF-RT", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "fb414df8-c9d8-42c8-8807-e699757de5d0", "code": "C07AA05", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS|Beta blocking agents, non-selective|propranolol", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07AA05&showdescription=yes", "code_system": "WHO-ATC", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "249051a7-0c6d-4462-8af4-c8472602d6d7", "code": "N0000175556", "comments": "Established Pharmacologic Class [EPC]|beta-Adrenergic Blocker [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175556", "code_system": "NDF-RT", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "00d49bc6-c91d-4139-9ce6-d752ffed88a6", "code": "QC07AA05", "comments": "VATC|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS|Beta blocking agents, non-selective|propranolol", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC07AA05&showdescription=yes", "code_system": "WHO-VATC", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "d222cbab-3d97-44f4-ba8c-59637979e349", "code": "C62073", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C62073", "code_system": "NCI_THESAURUS", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "9d377030-27c0-458e-b590-50e72c3f5e31", "code": "QC07BA05", "comments": "VATC|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS AND THIAZIDES|Beta blocking agents, non-selective and thiazides|propranolol and thiazides", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC07BA05&showdescription=yes", "code_system": "WHO-VATC", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "5f92c6fa-506d-4253-8bd4-e3265a7ee770", "code": "525-66-6", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=525-66-6", "code_system": "CAS", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541", "8d2b17ef-c4ae-4b87-a845-894917780048" ] }, { "uuid": "b11bcc6d-f5af-4ea4-9abe-3e13da29db77", "code": "D011433", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68011433", "code_system": "MESH", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "2fd82a99-cf35-4369-a899-1308654bbd79", "code": "NBK548218", "comments": "LiverTox|Cardiac|Antihypertensive|Beta blocker", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548218/", "code_system": "LIVERTOX", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "7763c5f6-14db-47a1-80f3-b684155dd01b", "code": "PROPRANOLOL", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Propranolol", "code_system": "WIKIPEDIA", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "dcae7103-b4e3-4147-ab8c-ca8ba677ac70", "code": "7.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Antimigraine medicines|For prophylaxis", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/163/?section=76#type427", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "de1feaaf-8923-4883-8149-1a70a5d14274", "code": "C07BA05", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS AND THIAZIDES|Beta blocking agents, non-selective, and thiazides|propranolol and thiazides", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07BA05&showdescription=yes", "code_system": "WHO-ATC", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "11a3f314-17e8-4e83-88ba-fc5a3e79f2c5", "code": "C07FA05", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES|Beta blocking agents, non-selective, and other antihypertensives|propranolol and other antihypertensives", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07FA05&showdescription=yes", "code_system": "WHO-ATC", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "7eed97e3-8289-4ad9-b709-7ce6ddd08aba", "code": "235-867-6", "type": "ALTERNATIVE", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.032.592", "code_system": "ECHA (EC/EINECS)", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "81cb419f-6840-4462-b1c8-865faf18b218", "code": "QC07FA05", "comments": "VATC|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES|Beta blocking agents, non-selective, and other antihypertensives|propranolol and other antihypertensives", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC07FA05&showdescription=yes", "code_system": "WHO-VATC", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "fb6f97bc-5706-4915-a892-596221695b8b", "code": "SUB10119MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "780f95e3-791c-4d1f-9be9-a2e6ad3a0e7b", "code": "1940", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=1940", "code_system": "INN", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "1a538f29-2672-40f4-ab83-ea6582dcb04a", "code": "564", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=564", "code_system": "IUPHAR", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "fb719608-8ea2-4d24-806c-cf683e40970d", "code": "8787", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/8787/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "69f836f1-861e-4e1d-9179-abcb2b6162cf", "code": "m9223", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m9223?q=authorize", "code_system": "MERCK INDEX", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "07587fe4-7c45-4030-84fb-a5441a42378d", "code": "DB00571", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00571", "code_system": "DRUG BANK", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "88ce4088-d5f0-4bfa-80ff-3c5d4d59e1da", "code": "13013-17-7", "type": "SUPERSEDED", "url": "https://commonchemistry.cas.org/detail?cas_rn=13013-17-7", "code_system": "CAS", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541", "4793ed41-b4d3-4895-a448-2119fdc8e34d" ] }, { "uuid": "5ff3ddc8-5cae-4357-a7ef-c5439c36afff", "code": "CHEMBL27", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27", "code_system": "ChEMBL", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "c07e5566-1faf-434b-b27f-19c28f49366f", "code": "208-378-0", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.007.618", "code_system": "ECHA (EC/EINECS)", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "8bd06be7-66ea-4f48-af91-c2b170195e02", "code": "4946", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4946", "code_system": "PUBCHEM", "references": [ "f00378b1-e5dd-4655-9aeb-be8615b11541" ] }, { "uuid": "ca3da822-368a-115c-453c-fcc941f1159d", "code": "DTXSID6023525", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID6023525", "code_system": "EPA CompTox", "references": [ "feed169e-996f-1b4c-f311-a37d32f1cc6d" ] }, { "uuid": "41d09733-6230-971e-88e5-68bbae6b2792", "code": "266708", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of proliferating infantile hemangiomas requiring systemic therapy", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=266708", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "e9953b54-a060-d2bb-85b2-51052024b2b5", "code": "C07FX01", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS, OTHER COMBINATIONS|Beta blocking agents, other combinations|propranolol and other combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07FX01&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "fec167fd-b36f-aec9-ca89-10dc8856a5ea", "code": "484315", "comments": "ORPHAN DRUG|Designated|Treatment of malignant glioma.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=484315", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "f03931b8-6d90-11ad-c01d-e94ac176e4bf", "code": "475715", "comments": "ORPHAN DRUG|Designated|Treatment of pancreatic cancer.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=475715", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "6364f765-a2ce-b7d0-749f-754933895567", "code": "C29576", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Adrenergic Agent[C29747]|Adrenergic Antagonist[C72900]|Beta-Adrenergic Antagonist", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29576", "code_system": "NCI_THESAURUS", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "cd117a04-f380-37d6-5107-2e82e1b2b472", "code": "703319", "comments": "ORPHAN DRUG|Designated|Treatment of retinopathy of prematurity", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=703319", "code_system": "FDA ORPHAN DRUG", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "63b8756d-56ba-a909-2ecb-c5333eac863d", "code": "EU/3/16/1805", "comments": "EU ORPHAN DRUG|Positive|Treatment of soft tissue sarcoma", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161805", "code_system": "EU-Orphan Drug", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "6ff43af5-f9bd-4c7b-8b81-17bb5fbb9f4a", "code": "9Y8NXQ24VQ", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "a67e6aaa-d672-fe2e-a238-db88b9137825", "code": "Propranolol", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM301/", "code_system": "LACTMED", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "d89e9975-d962-811e-ec3c-9b136d93bbe3", "code": "2303", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/2303", "code_system": "DRUG CENTRAL", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "3fc0b8dc-9794-8033-4448-9468d3e0088c", "code": "8499", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:8499", "code_system": "CHEBI", "references": [ "530e6604-7fdf-6f7e-edfe-25dcf5e83c11" ] }, { "uuid": "4453cb6c-9540-02a7-be5d-b1e460268f50", "code": "9Y8NXQ24VQ", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=9Y8NXQ24VQ", "code_system": "DAILYMED", "references": [ "a39821c0-8745-8f45-4286-1af6e246a65f" ] }, { "uuid": "44c2089f-7bdb-baaa-5a04-903b72cf1b37", "code": "100000092019", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "d9ecf2dc-b4eb-df0b-3560-84cc69d61bac" ] } ], "substance_class": "chemical", "references": [ { "uuid": "391da0db-3c60-478c-a3ee-741c00e9f239", "citation": "USP Dictionary", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "cf9b1f54-cb2e-4b64-9f5a-e9262da925db", "citation": "INN Proposed List 51", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL51.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "68f6915c-0e96-4c79-8428-a28c93f71cd1", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "citation": "MERCK INDEX", "doc_type": "MERCK INDEX", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9e92d637-07a3-4efc-a8bc-795977fec483", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "036a7f18-cd33-497d-a434-cb88a30ee7bc", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "beec9f81-0910-448a-bff3-59d9afca4072", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "605491f1-7909-4164-a91c-bbcf13c6bc8d", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f00378b1-e5dd-4655-9aeb-be8615b11541", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493390736000, "tags": [ "NOMEN" ] }, { "uuid": "3d20ec58-e16d-4000-b036-4b3b340ff5f0", "citation": "HANDBOOK OF CLINICAL PHARMACOKINETICS; EDS MILO GIBALDI AND LAURIE PRESCOTT; ADIS HEALTH SCIENCE PRESS; ISBN 0 86792 004 1; 1983", "doc_type": "BOOK", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fb79157e-3b92-4b05-8ebc-96b1f425bc23", "citation": "HTTP://WWW.ACCESSDATA.FDA.GOV/SPL/DATA/94674ABB-9B63-4684-8E32-567C07E13CBB/94674ABB-9B63-4684-8E32-567C07E13CBB.XML", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8e1d6676-faf7-4832-9c3a-3cd3e452351c", "citation": "JPET JULY 1972 VOL. 182 NO. 1 83-92", "url": "http://jpet.aspetjournals.org/content/182/1/83.full.pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "41d1a61f-b70a-469c-b70e-3d20425fb171", "citation": "JPET, JULY 1972 VOL. 182 NO. 1 83-92", "url": "http://jpet.aspetjournals.org/content/182/1/83.full.pdf+html", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5c98e1b9-e45a-48f2-8a47-07b7b8c79e2b", "citation": "http://www.accessdata.fda.gov/spl/data/94674abb-9b63-4684-8e32-567c07e13cbb/94674abb-9b63-4684-8e32-567c07e13cbb.xml", "url": "http://www.accessdata.fda.gov/spl/data/94674abb-9b63-4684-8e32-567c07e13cbb/94674abb-9b63-4684-8e32-567c07e13cbb.xml", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fb7679ce-92b0-4a3b-8007-030380561050", "citation": "DMD JULY 1983 VOL. 11 NO. 4 344-349", "url": "http://dmd.aspetjournals.org/content/11/4/344.full.pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "462e6d3e-b956-4b2b-8cfd-71ceb8799a54", "citation": "SRS import [9Y8NXQ24VQ]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=9Y8NXQ24VQ", "doc_type": "SRS", "public_domain": true, "document_date": 1493390736000, "tags": [ "NOMEN" ] }, { "uuid": "a6474896-6274-4c58-91f2-de3e3d06aef6", "citation": "PROPRANOLOL [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "adcb7751-4b66-46bb-b012-7d6ce373fe38", "citation": "PROPRANOLOL [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "537b22f2-187b-480b-8082-71c03a20327d", "citation": "PROPRANOLOL [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "9a3e30c0-7c04-4f8d-946e-4d5017fc0a58", "citation": "PROPRANOLOL [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "feed169e-996f-1b4c-f311-a37d32f1cc6d", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=525-66-6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "052ecac6-9700-e6ca-3ac6-468af2c67a8d", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+525-66-6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "40a8bbf3-392b-dff5-d32c-2cffbe6486b5", "citation": "Br J Clin Pharmacol. 1987 May; 23(5): 511–521.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1386186/pdf/brjclinpharm00113-0018.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "73ac405b-912f-7790-026e-7b47f33cce3e", "citation": "https://www.drugbank.ca/drugs/DB00571", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "d1bb08ce-5dc8-6c5a-ebcc-3a032223fb6e", "citation": "https://www.clinicalkey.com/pharmacology/monograph/522?sec=monphar", "doc_type": "CLINICAL PHARMACOLOGY", "public_domain": true }, { "uuid": "3d8cc953-c4aa-c3e6-8d3c-f8c69a2740b9", "citation": "https://en.wikipedia.org/wiki/Propranolol", "doc_type": "WIKI", "public_domain": true }, { "uuid": "530e6604-7fdf-6f7e-edfe-25dcf5e83c11", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "8d2b17ef-c4ae-4b87-a845-894917780048", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "4793ed41-b4d3-4895-a448-2119fdc8e34d", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "f0676730-9e6b-48cc-b02f-2180b010b35e", "citation": "J Chromatogr 1984;305(1):250", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "71ace37e-3585-4d91-acd6-a9ee7d517888", "citation": "J Chromatogr 123(1):185;1976", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e4fc9c0c-29aa-415e-b7dd-cfb6512007f5", "citation": "Res Commun Chem Pathol Pharmacol 1983;42(2):235", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "24558546-3ea3-499b-849d-f56642180e8e", "citation": "J Chromatogr 145(3):429;1978", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "626a0c31-48b5-4c32-a857-eccb19208827", "citation": "SCIFINDER", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4e60d724-25da-4592-9106-a85c3689dab5", "citation": "Life Sciences Volume 6, Issue 9, 1 May 1967, Pages 939-950", "url": "https://www.sciencedirect.com/science/article/pii/002432056790080X", "doc_type": "JA", "public_domain": true }, { "uuid": "a39821c0-8745-8f45-4286-1af6e246a65f", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "55adaf19-80ef-2a71-7070-ca6bc31c79c6", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "d9ecf2dc-b4eb-df0b-3560-84cc69d61bac", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "8ad5fe41-bd48-40a9-80e4-9e5b12026c64", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b9404d92-61ff-4da6-a881-ad5fc07bfeed", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/20", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/20", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "a4f4428d-e8ee-48ee-a589-139d7d1a648a", "citation": "Smith, M. T., et al. \"Chronic propranolol administration during pregnancy: maternal pharmacokinetics.\" European journal of clinical pharmacology 25 (1983): 481-490.", "url": "https://link.springer.com/article/10.1007/BF00542115", "doc_type": "JA", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "e7626980-4b23-4852-871c-c4bbef640d23", "id": "e7626980-4b23-4852-871c-c4bbef640d23", "molfile": "\n CDK 09192419432D\n\n 19 20 0 0 0 0 0 0 0 0999 V2000\n 21.1656 -8.1182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.1656 -6.5582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5045 -5.7682 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 23.8651 -6.5262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.2104 -5.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.5708 -6.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.9161 -5.6772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 29.2770 -6.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.2770 -8.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 30.6115 -5.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.2104 -4.1564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 19.7853 -5.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 18.4765 -6.5912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 18.4765 -8.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.8514 -8.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.8514 -10.4669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.2490 -11.2356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5666 -10.4396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5666 -8.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 2 0 0 0 0\n 3 2 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 4 1 0 0 0 0\n 6 5 1 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 1 0 0 0 0\n 9 8 1 0 0 0 0\n 10 8 1 0 0 0 0\n 5 11 1 0 0 0 0\n 12 2 2 0 0 0 0\n 12 13 1 0 0 0 0\n 13 14 2 0 0 0 0\n 14 15 1 0 0 0 0\n 15 1 2 0 0 0 0\n 16 15 1 0 0 0 0\n 17 16 2 0 0 0 0\n 17 18 1 0 0 0 0\n 18 19 2 0 0 0 0\n 19 1 1 0 0 0 0\nM END", "smiles": "CC(C)NCC(COC=1=CC=CC2=C1C=CC=C2)O", "formula": "C16H21NO2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "2d15a85d-f290-4b50-b123-7b13f5cc39c4" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "259.344", "optical_activity": "( + / - )", "stereo_centers": 1 } ], "definition_level": "COMPLETE", "uuid": "34c64635-750a-4716-a3ad-7eb4381eb801", "version": "54", "structure": { "id": "4fe52151-85ac-45c6-ba9e-39ff6bedd51b", "molfile": "\n JSDraw209192419432D\n\n 19 20 0 0 0 0 0 V2000\n 21.1656 -8.1182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.1656 -6.5582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5045 -5.7682 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 23.8651 -6.5262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.2104 -5.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.5708 -6.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.9161 -5.6772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 29.2770 -6.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.2770 -8.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 30.6115 -5.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.2104 -4.1564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 19.7853 -5.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 18.4765 -6.5912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 18.4765 -8.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.8514 -8.9084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.8514 -10.4669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.2490 -11.2356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5666 -10.4396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5666 -8.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 2 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 4 1 0 0 0 0\n 6 5 1 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 1 0 0 0 0\n 9 8 1 0 0 0 0\n 10 8 1 0 0 0 0\n 5 11 1 0 0 0 0\n 12 2 2 0 0 0 0\n 12 13 1 0 0 0 0\n 13 14 2 0 0 0 0\n 14 15 1 0 0 0 0\n 15 1 2 0 0 0 0\n 16 15 1 0 0 0 0\n 17 16 2 0 0 0 0\n 17 18 1 0 0 0 0\n 18 19 2 0 0 0 0\n 19 1 1 0 0 0 0\nM END", "smiles": "CC(C)NCC(COc1cccc2ccccc21)O", "formula": "C16H21NO2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "259.344", "optical_activity": "( + / - )", "references": [ "391da0db-3c60-478c-a3ee-741c00e9f239", "462e6d3e-b956-4b2b-8cfd-71ceb8799a54", "cf9b1f54-cb2e-4b64-9f5a-e9262da925db" ], "stereo_centers": 1 }, "unii": "9Y8NXQ24VQ", "relationships": [ { "uuid": "804c8f54-bf81-4137-929c-c59759823a3b", "amount": { "uuid": "68c5ca7e-b2ba-4ad1-a101-c2cc1a740bbf" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "2b2588c1-65b4-47f0-8144-bb29c193b08f", "refuuid": "34c64635-750a-4716-a3ad-7eb4381eb801", "name": "PROPRANOLOL", "unii": "9Y8NXQ24VQ", "linking_id": "9Y8NXQ24VQ", "ref_pname": "PROPRANOLOL", "substance_class": "reference" } }, { "uuid": "b3995570-c82f-473f-8d77-9000777958d9", "amount": { "uuid": "ef36e554-c604-49a7-bbfe-28a488a2b4ef" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "0ee74e83-64cf-408d-9048-55e0b2f3dadd", "refuuid": "9b2211f3-e154-4cf0-bb27-a5366c7dd113", "name": "Propranolol hydrochloride", "unii": "F8A3652H1V", "linking_id": "F8A3652H1V", "ref_pname": "Propranolol hydrochloride", "substance_class": "reference" } }, { "uuid": "e153d16b-3267-49ff-b429-450e43d294d6", "amount": { "uuid": "44a00e7d-a222-4b63-b0cf-2ec87dba554c", "type": "RELATIONSHIP_AMOUNT", "units": "METABOLITE/PARENT RATIO", "high_limit": 1.3, "low_limit": 0.2 }, "comments": "Metabolite to parent drug ratio in non-uraemic human plasma after chronic administration of parent drug.", "qualification": "PLASMA; URINE", "type": "METABOLITE ACTIVE->PARENT", "interaction_type": "METABOLITE TO PARENT DRUG RATIO", "references": [ "3d20ec58-e16d-4000-b036-4b3b340ff5f0" ], "related_substance": { "uuid": "6a8b0a2b-71a2-4673-86df-9b27e6e22d4f", "refuuid": "da9f50a1-7c4b-4cf1-8551-095fc5dc8f25", "name": "4-HYDROXYPROPRANOLOL", "unii": "2449QP4SVP", "linking_id": "2449QP4SVP", "ref_pname": "4-HYDROXYPROPRANOLOL", "substance_class": "reference" } }, { "uuid": "49db4d83-eca4-4dbd-80da-ebb05861c004", "amount": { "uuid": "45d3f204-b262-4c62-952d-05d7ae903826" }, "comments": "In vitro studies have indicated that the aromatic hydroxylation of propranolol is catalyzed mainly by polymorphic CYP2D6.", "type": "METABOLITE ACTIVE->PARENT", "references": [ "fb79157e-3b92-4b05-8ebc-96b1f425bc23" ], "related_substance": { "uuid": "d0f8365d-2d63-48c8-92d0-d54df4bd17e2", "refuuid": "da9f50a1-7c4b-4cf1-8551-095fc5dc8f25", "name": "4-HYDROXYPROPRANOLOL", "unii": "2449QP4SVP", "linking_id": "2449QP4SVP", "ref_pname": "4-HYDROXYPROPRANOLOL", "substance_class": "reference" } }, { "uuid": "fd0a4196-ae18-459b-a76d-6a83f87a5dd5", "amount": { "uuid": "f0110306-d9c0-4704-ab30-2f7b164e5298" }, "qualification": "URINE", "type": "METABOLITE ACTIVE->PARENT", "interaction_type": "MAJOR", "references": [ "24558546-3ea3-499b-849d-f56642180e8e" ], "related_substance": { "uuid": "3c82f6e2-0c3c-4fbd-b8af-d46b80496aff", "refuuid": "da9f50a1-7c4b-4cf1-8551-095fc5dc8f25", "name": "4-HYDROXYPROPRANOLOL", "unii": "2449QP4SVP", "linking_id": "2449QP4SVP", "ref_pname": "4-HYDROXYPROPRANOLOL", "substance_class": "reference" } }, { "uuid": "bbddadb8-f489-4291-be70-e1baff49027e", "amount": { "uuid": "136a1374-5378-47c8-b0c8-90a6b8cc7979" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "references": [ "71ace37e-3585-4d91-acd6-a9ee7d517888" ], "related_substance": { "uuid": "bbd2d6b1-3277-4ec7-9c90-8a7e80a44175", "refuuid": "002baed5-b661-4044-bc59-b0e5d14d2aa3", "name": "Propranolol glycol", "unii": "FU45BO16RF", "linking_id": "FU45BO16RF", "ref_pname": "Propranolol glycol", "substance_class": "reference" } }, { "uuid": "b249e856-b39f-4496-829c-0e7f9c551bb5", "amount": { "uuid": "4b703022-4435-4d00-b584-d96affcb21cd" }, "comments": "In vitro studies have indicated that the aromatic hydroxylation of propranolol is catalyzed mainly by polymorphic CYP2D6. Side-chain oxidation is mediated mainly by CYP1A2 and to some extent by CYP2D6.", "type": "METABOLITE->PARENT", "references": [ "fb79157e-3b92-4b05-8ebc-96b1f425bc23" ], "related_substance": { "uuid": "de6a00ff-0c3f-4f10-8cb6-90e0d970e3b4", "refuuid": "379a7ce4-aee0-4403-bc44-d2873af5f72a", "name": "4-HYDROXY-PROPRANOLOL GLYCOL", "unii": "V376P00JP8", "linking_id": "V376P00JP8", "ref_pname": "4-HYDROXY-PROPRANOLOL GLYCOL", "substance_class": "reference" } }, { "uuid": "fe7cfaba-2825-4156-aaf5-c13d65362527", "amount": { "uuid": "0f6bec1e-d231-4a6e-a01a-908bda07ad66" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "references": [ "e4fc9c0c-29aa-415e-b7dd-cfb6512007f5" ], "related_substance": { "uuid": "16345319-cbf7-4357-8fd5-f90168084362", "refuuid": "379a7ce4-aee0-4403-bc44-d2873af5f72a", "name": "4-HYDROXY-PROPRANOLOL GLYCOL", "unii": "V376P00JP8", "linking_id": "V376P00JP8", "ref_pname": "4-HYDROXY-PROPRANOLOL GLYCOL", "substance_class": "reference" } }, { "uuid": "8e7361bb-ae50-4568-a311-7c45ce2c8736", "amount": { "uuid": "e8d4584d-f282-41b5-b5de-87d9ca00b127" }, "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "5c98e1b9-e45a-48f2-8a47-07b7b8c79e2b" ], "related_substance": { "uuid": "301d8154-9aa1-4b83-9da8-ece481507a81", "refuuid": "20d579e4-2fa3-4dff-be05-de2de8ea9fd1", "name": "PROPRANOLOL GLUCURONIDE", "unii": "64CG9RE9H6", "linking_id": "64CG9RE9H6", "ref_pname": "PROPRANOLOL GLUCURONIDE", "substance_class": "reference" } }, { "uuid": "ad457c7b-0f88-4278-b6ad-271177faa11b", "amount": { "uuid": "b0539389-2472-41de-ae2d-fece6ca44b71" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "references": [ "8e1d6676-faf7-4832-9c3a-3cd3e452351c" ], "related_substance": { "uuid": "694a075e-b4a8-4d64-a520-91fe92222c4b", "refuuid": "e8153954-5c3b-4f04-a81d-e4d11e296f73", "name": "1-NAPHTHOXYACETIC ACID", "unii": "9QI2464POA", "linking_id": "9QI2464POA", "ref_pname": "1-NAPHTHOXYACETIC ACID", "substance_class": "reference" } }, { "uuid": "7ab0baf6-c444-4742-9b42-906f8d62ca55", "amount": { "uuid": "71cc4786-13ad-4eb6-b103-9f55c486cd34" }, "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "5c98e1b9-e45a-48f2-8a47-07b7b8c79e2b" ], "related_substance": { "uuid": "824724e5-1f48-44c1-b308-c67708611cf0", "refuuid": "e8153954-5c3b-4f04-a81d-e4d11e296f73", "name": "1-NAPHTHOXYACETIC ACID", "unii": "9QI2464POA", "linking_id": "9QI2464POA", "ref_pname": "1-NAPHTHOXYACETIC ACID", "substance_class": "reference" } }, { "uuid": "88718fad-e429-4962-afae-8e419823c430", "amount": { "uuid": "00d3d7d3-c043-4db7-8536-ca95d2b8fb9a" }, "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "5c98e1b9-e45a-48f2-8a47-07b7b8c79e2b" ], "related_substance": { "uuid": "fe4abff2-1e88-4cb9-8390-555de0b776e3", "refuuid": "f909537a-2712-4c3a-85b0-88eab260a930", "name": "4-HYDROXYPROPRANOLOL GLUCURONIDE", "unii": "VY58B6SD7Z", "linking_id": "VY58B6SD7Z", "ref_pname": "4-HYDROXYPROPRANOLOL GLUCURONIDE", "substance_class": "reference" } }, { "uuid": "aa305df8-38a2-4802-ba01-6314ef421abf", "amount": { "uuid": "32688843-8144-4e8f-bac9-cdd6b3012c87" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "f0676730-9e6b-48cc-b02f-2180b010b35e" ], "related_substance": { "uuid": "5f9722df-ebac-42a2-af90-1abfd8ef9dbb", "refuuid": "25ca0375-d6a9-4bf0-abd9-0aa4590d624d", "name": "4-HYDROXYPROPRANOLOL-4-O-SULFATE", "unii": "FRG22A758K", "linking_id": "FRG22A758K", "ref_pname": "4-HYDROXYPROPRANOLOL-4-O-SULFATE", "substance_class": "reference" } }, { "uuid": "a9521ae0-5763-4e1a-abad-cd3bc46925be", "amount": { "uuid": "443b357f-19f0-44c8-9ab3-5938790a0537" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "def5c7a3-33ce-4588-8931-cb2d3802f8b1", "refuuid": "6fcfc30c-979e-4aeb-88c7-33a2b25b0881", "name": "DEXPROPRANOLOL", "unii": "PG6KY07UD7", "linking_id": "PG6KY07UD7", "ref_pname": "DEXPROPRANOLOL", "substance_class": "reference" } }, { "uuid": "7c2a03dc-af9b-4631-8c71-401b92adf976", "amount": { "uuid": "2d0c4ae3-bddc-4268-9d6b-4d5b9f5b983d" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "5db10e67-1847-459e-8819-c18fb2f6c60f", "refuuid": "52029b76-c163-47e0-bfab-8f8a02809c99", "name": "LEVOPROPRANOLOL", "unii": "74MLR03FLC", "linking_id": "74MLR03FLC", "ref_pname": "LEVOPROPRANOLOL", "substance_class": "reference" } }, { "uuid": "ede64813-0b13-4225-ab92-af9deaa02b25", "amount": { "uuid": "b6757cad-0f8e-4669-8385-4c8642179652", "high": 2.69, "low": 0.2, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->INHIBITOR", "references": [ "3d8cc953-c4aa-c3e6-8d3c-f8c69a2740b9" ], "related_substance": { "uuid": "bf4fb7fd-cbc3-42ce-8139-70205e47a696", "refuuid": "439f9520-949b-423a-b8bc-a7389fc6ba24", "name": "BETA-1 ADRENERGIC RECEPTOR", "unii": "4A4MK4KIB5", "linking_id": "4A4MK4KIB5", "ref_pname": "BETA-1 ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "c791969f-a793-4b80-aac8-bc5f6d8a588f", "amount": { "uuid": "20bfc8e4-2ebd-4773-8142-f7c78e245751", "high": 0.61, "low": 0.01, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->INHIBITOR", "interaction_type": "COMPETITIVE INHIBITOR", "references": [ "3d8cc953-c4aa-c3e6-8d3c-f8c69a2740b9" ], "related_substance": { "uuid": "ad6f1551-a331-4df7-8e72-7e5a75679720", "refuuid": "48fe719b-afcc-496a-958b-9130d8f620f4", "name": "BETA-2 ADRENERGIC RECEPTOR", "unii": "VZX139UJO5", "linking_id": "VZX139UJO5", "ref_pname": "BETA-2 ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "ae24d144-4c4c-4091-abe4-96a491ce100e", "amount": { "uuid": "817a7a46-e925-4673-945a-6da73f139ae6" }, "type": "METABOLIC ENZYME->SUBSTRATE", "related_substance": { "uuid": "376ac67a-2a07-420f-866d-b0278bbcd852", "refuuid": "1b41bc94-8610-42e2-b998-11fc453053d8", "name": "CYTOCHROME P450 2D15 (CANINE)", "unii": "2XX4SF4LD9", "linking_id": "2XX4SF4LD9", "ref_pname": "CYTOCHROME P450 2D15 (CANINE)" } }, { "uuid": "c51ab19d-201c-4847-ae74-3c69306c6d05", "amount": { "uuid": "9de7fb9d-1020-40d1-bef1-6a7ebc5aff35" }, "type": "IMPURITY->PARENT", "references": [ "626a0c31-48b5-4c32-a857-eccb19208827" ], "related_substance": { "uuid": "671b123b-7afb-4f7d-ac22-e3726b8c3b9f", "refuuid": "6d3fca33-3125-4bcc-975e-f0959d85e74b", "name": "2-PROPANOL, 1,1'-OXYBIS(3-(1-NAPHTHALENYLOXY)-", "unii": "A5EM7RT7Q3", "linking_id": "A5EM7RT7Q3", "ref_pname": "2-PROPANOL, 1,1'-OXYBIS(3-(1-NAPHTHALENYLOXY)-" } }, { "uuid": "fa294d13-7133-4308-8cd0-359b20c09147", "amount": { "uuid": "bc7fe1f4-7495-4e68-851c-14180b55d416" }, "type": "ACTIVE ENANTIOMER->RACEMATE", "references": [ "4e60d724-25da-4592-9106-a85c3689dab5" ], "related_substance": { "uuid": "76afcedb-fd0b-47fa-a66a-2b238d16becc", "refuuid": "52029b76-c163-47e0-bfab-8f8a02809c99", "name": "LEVOPROPRANOLOL", "unii": "74MLR03FLC", "linking_id": "74MLR03FLC", "ref_pname": "LEVOPROPRANOLOL", "substance_class": "reference" } }, { "uuid": "9d85245e-8d33-4b0e-bd3e-1c02ddeca0e9", "amount": { "uuid": "9732f2c7-4f93-48c2-96bf-9181defac9d4", "average": 1.6, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "TARGET->INHIBITOR", "references": [ "b9404d92-61ff-4da6-a881-ad5fc07bfeed" ], "related_substance": { "uuid": "cbc478b5-9819-4107-8cb6-8286a5863b82", "refuuid": "48fe719b-afcc-496a-958b-9130d8f620f4", "name": "BETA-2 ADRENERGIC RECEPTOR", "unii": "VZX139UJO5", "linking_id": "VZX139UJO5", "ref_pname": "BETA-2 ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "70faab9f-36a4-4fa0-947f-3409b4638ea2", "amount": { "uuid": "eb7b73ac-12aa-437d-b655-4ab985a8dcfc" }, "type": "METABOLITE->PARENT", "references": [ "a4f4428d-e8ee-48ee-a589-139d7d1a648a" ], "related_substance": { "uuid": "552a9197-f08a-47f0-82cd-bef42b255b0c", "refuuid": "944d516c-8e29-4d3f-ba4b-8ada954f4e1d", "name": "α-Naphthoxylactic acid", "unii": "E2K6PH4HYV", "linking_id": "E2K6PH4HYV", "ref_pname": "α-Naphthoxylactic acid", "substance_class": "reference" } } ], "names": [ { "uuid": "23a5b094-7933-4a9e-9a8c-e51a5f52e1a3", "name": "(±)-PROPRANOLOL", "stdName": "(+/-)-PROPRANOLOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "51e52d44-9781-406f-a7af-a0824eaae85f", "name": ".BETA.-PROPRANOLOL", "stdName": ".BETA.-PROPRANOLOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "93519256-4bf2-42e0-8187-03acb958d766", "name": "1-((1-METHYLETHYL)AMINO)-3-(1-NAPHTHALENYLOXY)-2-PROPANOL", "stdName": "1-((1-METHYLETHYL)AMINO)-3-(1-NAPHTHALENYLOXY)-2-PROPANOL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "8a66dc6a-7a90-4c76-b6e6-e8c2339cf815", "name": "2-PROPANOL, 1-((1-METHYLETHYL)AMINO)-3-(1-NAPHTHALENYLOXY)-", "stdName": "2-PROPANOL, 1-((1-METHYLETHYL)AMINO)-3-(1-NAPHTHALENYLOXY)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "36411f12-bdc5-44d2-aca2-b61cd678ee76", "name": "AY-64043-", "stdName": "AY-64043-", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "d4ff1d03-ce9e-454f-b567-3da6facffa1d", "name": "BETALONG", "stdName": "BETALONG", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "71eaa377-2816-4f2c-93b2-322dace35c62", "name": "DL-PROPRANOLOL", "stdName": "DL-PROPRANOLOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "beec9f81-0910-448a-bff3-59d9afca4072", "de821f05-60dc-477b-8bf6-b42b4bb6f4e8" ], "display_name": false }, { "uuid": "bc2f6ed7-6038-42ac-9589-bcc1023e7f25", "name": "EUPROVASIN", "stdName": "EUPROVASIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "0b3c9fc9-986e-40de-a509-9b76a163243b", "name": "INNOPRAN XL", "stdName": "INNOPRAN XL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "ad881fec-d445-45ad-80c9-70f70c9b08dc", "name": "PROPRANOLOL", "stdName": "PROPRANOLOL", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "9e92d637-07a3-4efc-a8bc-795977fec483", "036a7f18-cd33-497d-a434-cb88a30ee7bc", "a6474896-6274-4c58-91f2-de3e3d06aef6", "adcb7751-4b66-46bb-b012-7d6ce373fe38", "9a3e30c0-7c04-4f8d-946e-4d5017fc0a58", "391da0db-3c60-478c-a3ee-741c00e9f239", "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "68f6915c-0e96-4c79-8428-a28c93f71cd1", "537b22f2-187b-480b-8082-71c03a20327d", "cf9b1f54-cb2e-4b64-9f5a-e9262da925db" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "a150c4dc-564a-4916-890b-d28f028d6f47", "name_org": "INN" } ] }, { "uuid": "4a2c0fa9-7900-4979-ae34-0a9750b2982c", "name": "PROPRANOLOL [MI]", "stdName": "PROPRANOLOL [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "68f6915c-0e96-4c79-8428-a28c93f71cd1" ], "display_name": false }, { "uuid": "349b09bb-d161-4c91-867a-ed6e71d5897f", "name": "PROPRANOLOL [VANDF]", "stdName": "PROPRANOLOL [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "036a7f18-cd33-497d-a434-cb88a30ee7bc", "de821f05-60dc-477b-8bf6-b42b4bb6f4e8" ], "display_name": false }, { "uuid": "aa9c527a-7add-4009-947e-a8417175a65f", "name": "PROPRASYLYT", "stdName": "PROPRASYLYT", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "03f6f372-6dc4-8c8e-4190-eba933b35b00", "name": "Propranolol [WHO-DD]", "stdName": "PROPRANOLOL [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "55adaf19-80ef-2a71-7070-ca6bc31c79c6" ], "display_name": false }, { "uuid": "2ae2bf6f-d357-4148-8fab-a6f510dadd80", "name": "REDUCOR", "stdName": "REDUCOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de821f05-60dc-477b-8bf6-b42b4bb6f4e8", "605491f1-7909-4164-a91c-bbcf13c6bc8d" ], "display_name": false }, { "uuid": "e24756d4-5cff-46c0-9943-70d7c4e3a4a7", "name": "propranolol [INN]", "stdName": "PROPRANOLOL [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cf9b1f54-cb2e-4b64-9f5a-e9262da925db" ], "display_name": false } ], "properties": [ { "uuid": "f2d7b348-6210-49cc-b80c-b3101d6f2c25", "name": "Volume of Distribution", "value": { "uuid": "1e65d8c8-4104-4c53-bf62-d275a242f5a6", "average": 4, "units": "Liters/Kilogram" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "d1bb08ce-5dc8-6c5a-ebcc-3a032223fb6e" ] }, { "uuid": "3c78ae7a-07b6-4ecd-b386-bc2efdf95dd8", "name": "Biological Half-life", "value": { "uuid": "58b007f2-7915-403a-b0a9-9f7f33596edf", "average": 3.11, "high": 3.68, "low": 2.54 }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "40a8bbf3-392b-dff5-d32c-2cffbe6486b5" ] } ] } ] }